Methocarbamol and Calan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methocarbamol (methocarbamol) and Calan (verapamil hydrochloride). Common drug interactions include fatigue among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Methocarbamol and Calan. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Methocarbamol?
Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.
What is Calan?
Calan has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,916 Calan users. Check the latest studies of Calan.
16 people who take Methocarbamol and Calan together, and have interactions are studied.

What are the common drug interactions of Methocarbamol and Calan, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
- Arthralgia (joint pain)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Chronic obstructive airways disease
- Fall
- Head injury
- Hypoaesthesia (reduced sense of touch or sensation)
male:
- Chronic kidney disease
- Glomerulonephritis minimal lesion (a disease of the kidney that causes nephrotic syndrome and usually affects children)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Renal failure (kidney dysfunction)
- Acute left ventricular failure (heart attack)
- Acute myocardial infarction (acute heart attack)
- Cardiac failure
- Cardiac failure congestive
- Cardiovascular disorder (heart diseases)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
What are the common drug interactions of Methocarbamol and Calan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
30-39:
n/a
40-49:
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Arthralgia (joint pain)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Chronic obstructive airways disease
- Fall
- Head injury
- Headache (pain in head)
- Hypoaesthesia (reduced sense of touch or sensation)
- Hypoxia (low oxygen in tissues)
50-59:
n/a
60+:
- Chronic kidney disease
- Glomerulonephritis minimal lesion (a disease of the kidney that causes nephrotic syndrome and usually affects children)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Renal failure (kidney dysfunction)
- Acute left ventricular failure (heart attack)
- Acute myocardial infarction (acute heart attack)
- Cardiac failure
- Cardiac failure congestive
- Cardiovascular disorder (heart diseases)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
What are the existing conditions these people have? *
- Nausea (feeling of having an urge to vomit): 6 people, 37.50%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 37.50%
- Pain: 6 people, 37.50%
- High Blood Cholesterol: 4 people, 25.00%
- Nausea And Vomiting: 4 people, 25.00%
- Depression: 4 people, 25.00%
- Multiple Allergies (allergy to multiple agents): 3 people, 18.75%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
- Stress And Anxiety: 3 people, 18.75%
- Infection: 3 people, 18.75%
* Approximation only. Some reports may have incomplete information.
Do you take Methocarbamol and Calan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methocarbamol (17,766 reports)
- Calan (3,916 reports)
Browse all drug interactions of Methocarbamol and Calan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methocarbamol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Calan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methocarbamol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Calan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methocarbamol and verapamil hydrochloride (the active ingredients of Methocarbamol and Calan, respectively), and Methocarbamol and Calan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Gilenya and Endep - 8 seconds ago
- Could Benlysta cause Weight Abnormal? - 10 seconds ago
- Arterial Occlusive Disease and Stable Angina - 16 seconds ago
- Drug interactions of Pulmicort and Robinul - 23 seconds ago
- Drug interactions of Anzemet and Acetaminophen - 35 seconds ago
- Could Diprolene cause Cataract? - 41 seconds ago
- Drug interactions of Cidofovir and Cyclophosphamide - a minute ago
- Could Sumatriptan cause Melaena? - a minute ago
- Could Marcaine cause Face Oedema? - a minute ago
- Rasilez vs. Zide, side effect and effectiveness comparison - a minute ago